Does nitric oxide play a critical role in viral infections?

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4547-4551

  Reiss, Carol Shoshkes ^a   Komatsu, Takashi ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0031903001     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4547-4551.1998     Document Type: Article

References (48)

1. Adler, H., J. L. Beland, N. C. Del-Pan, L. Kobzik, J. P. Brewer, T. R. Martin, and I. Kimm. 1997. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS-2). J. Exp. Med. 185:1533-1540.
2. Akaike, T., E. Weihe, M. Schaefer, Z. F. Fu, Y. M. Zheng, W. Vogel, H. Schmidt, H. Koprowski, and B. Dietzschold. 1995. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J. Neurovirol. 1:118-125.
3. Akarid, K., M. Sinet, B. Desforges, and M. A. Gougerot-Pocidalo. 1995. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69:7001-7005.
4. Anstey, N. M., J. B. Weinberg, M. Y. Hassanali, E. D. Mwaikambo, D. Manyenga, M. A. Misukonis, D. R. Arnelle, D. Hollis, M. I. McDonald, and D. L. Granger. 1996. Nitric oxide in Tanzanian children with malaria: inverse relationship between severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184:557-567.
5. Barna, M., T. Komatsu, and C. S. Reiss. 1996. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223:331-343.
6. Bi, Z., and C. S. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
7. Bredt, D. S., and S. H. Snyder. 1994. Nitric oxide: a physiological messenger molecule. Annu. Rev. Biochem. 63:175-195.
8. Burnett, A. L., C. J. Lowenstein, D. S. Bredt, T. S. K. Chang, and S. H. Snyder. 1992. Nitric oxide: a physiological mediator of penile erection. Science 257:401-404.
9. Campbell, I. L., A. Samimi, and C.-S. Chiang. 1994. Expression of the inducible nitric oxide synthase: correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J. Immunol. 153:3622-3629.
10. Dawson, T. M., and V. L. Dawson. 1994. Nitric oxide: actions and pathologic roles. Neuroscientist 1:9-20.
11. DeGroot, C. J. A., S. R. Ruuls, J. W. M. Theeuwes, C. D. Dijkstra, and P. van der Valk. 1997. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:10-20.
12. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2413.
13. Ding, J. M., L. E. Faiman, W. J. Hurst, L. R. Kuriashkina, and M. U. Gillette. 1997. Resetting the biological clock: mediation of nocturnal CREB phosphorylation via light, glutamate, and nitric oxide. J. Neurosci. 17:667-675.
14. Grzybicki, D. A., K. B. Kwack, S. Perlman, and S. P. Murphy. 1997. Nitric oxide synthase type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent infection. J. Neuroimmunol. 73:15-27.
15. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
16. Harris, N., R. M. L. Buller, and G. Karupiah. 1995. Gamma interferon-induced nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:910-915.
17. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura. S. J. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-1615.
18. Karupiah, G., Q.-w. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445-1448.
19. Koka, P., K. He, J. A. Zack, S. Kitchen, W. Peacock, I. Fried, T. Tran, S. S. Yashar, and J. E. Merrill. 1995. Human immunodeficiency virus 1 envelope protein induces interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182:941-952.
20. Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-γ induced type 1 nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101-108.
21. 20a. Komatsu, T., et al. Unpublished data.
22. Kong, L.-Y., B. C. Wilson, M. K. McMillan, G. Bing, P. M. Hudson, and J.-S. Hong. 1996. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell. Immunol. 172:77-83.
23. Koprowski, H., Y. M. Zheng, E. Heber-Katz, N. Fraser, L. Rorke, Z. F. Fu, C. Hanlon, and B. Dietzschold. 1993. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Proc. Natl. Acad. Sci. USA 90:3024-3027.
24. Kreil, T. R., and M. M. Eibl. 1996. Nitric oxide and viral infection: no antiviral activity against a flavivirus in vitro and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 219:304-306.
25. Lane, T. E., A. D. Paoletti, and M. J. Buchmeier. 1997. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J. Virol. 71:2202-2210.
26. Levy, D. E. 1997. The house that JAK/STAT built. Cytokine Growth Factor Rev. 8:81-90.
27. Lin, Y.-L., Y.-L. Huang, S.-H. Ma, C.-T. Yeh, S.-Y. Chiou, L.-K. Chen, and C.-L. Liao. 1997. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of NO on RNA virus replication. J. Virol. 71:5227-5235.
28. Lopez-Guerrero, J. A., and L. Carrasco. 1998. Effect of nitric oxide on poliovirus infection of two human cell lines. J. Virol. 72:2538-2540.
29. Lowenstein, C. J., G. Allen, N. Rose, S. H. Snyder, and A. Herskowitz. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1837-1843.
30. 28a. Lowenstein, C. J. Personal communication.
31. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus replication. Cell 79:1137-1146.
32. Melkova, Z., and M. Esteban. 1995. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155: 5711-5718.
33. Nathan, C., and Q.-w. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
34. O'Dell, T. J., R. D. Hawkins, E. R. Kandel, and O. Arancio. 1991. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. USA 88:11285-11289.
35. Oleszak, E. L., C. D. Katsetos, J. Kuzmak, and A. Varadhachary. 1997. Inducible nitric oxide synthase in Theiler's murine encephalitis virus infection. J. Virol. 71:3228-3235.
36. O'Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction, and immuno-regulation: are we there yet? Immunity 7:1-11.
37. Palmer, R. M., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
38. Raber, J., S. M. Toggas, S. Lee, F. E. Bloom, C. J. Epstein, and L. Mucke. 1996. Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology 226:362-373.
39. Rolph, M. S., I. A. Ramshaw, K. A. Rockett, J. Ruby, and W. B. Cowden. 1996. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology 217:470-177.
40. Rowland, R. R. R., E. A. Butz, and P. G. W. Plagemann. 1994. Nitric oxide production by splenic macrophages is not responsible for the T cell suppression during acute infection with lactate dehydrogenase-elevating virus. J. Immunol. 152:5785-5795.
41. Sanders, S. P., E. S. Sierkierski, J. D. Porter, S. M. Richards, and D. Proud. 1998. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 72:934-942.
42. Shiraishi, A., J. Didler, and M. Lotz. 1997. The role of IRF-1 in synovitis and nitric oxide production. J. Immunol. 159:3549-3554.
43. Srivastava, A., et al. Unpublished data.
44. Staeheli, P. 1990. Interferon-inducibie proteins and the anti-viral state. Adv. Virus Res. 38:147-200.
45. Stamler, J. S. 1996. A radical vascular connection. Nature 380:108-111.
46. Tay, C. H., and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.
47. Tucker, P. C., D. E. Griffin, S. Choi, N. Bul, and S. Wesselingh. 1996. Inhibition of nitric oxide synthase increases the mortality in Sindbis virus encephalitis. J. Virol. 70:3972-3977.
48. Zaragoza, C., C. J. Ocampo, M. Saura, A. McMillan, and C. J. Lowenstein. 1997. Nitric oxide inhibition of coxsackie virus replication in vitro. J. Clin. Invest. 100:1760-1767.